{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:56:31Z","timestamp":1791410191105,"version":"4.3.3"},"reference-count":228,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK123292"],"award-info":[{"award-number":["R01 DK123292"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK131059"],"award-info":[{"award-number":["R01 DK131059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK112217"],"award-info":[{"award-number":["U01 DK112217"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2004-03813"],"award-info":[{"award-number":["2004-03813"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["2018PG-T1D053"],"award-info":[{"award-number":["2018PG-T1D053"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["5-SRA-2018-557-Q-R"],"award-info":[{"award-number":["5-SRA-2018-557-Q-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["G-2108-04793"],"award-info":[{"award-number":["G-2108-04793"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cmet.2023.06.018","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T11:37:19Z","timestamp":1689853039000},"page":"1500-1518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["The pathogenic \u201csymphony\u201d in type 1 diabetes: A disorder of the immune system, \u03b2 cells, and exocrine pancreas"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-4782","authenticated-orcid":false,"given":"Mark A.","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra G.","family":"Mirmira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2023.06.018_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2023.06.018_bib2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0932-x","article-title":"Emerging concepts on disease-modifying therapies in type 1 diabetes","volume":"17","author":"Greenbaum","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib5","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2023.06.018_bib6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dbi18-0034","article-title":"Etiology of autoimmune islet disease: timing is everything","volume":"70","author":"Lernmark","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S2213-8587(21)00344-2","article-title":"The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still","volume":"10","author":"Michels","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S2213-8587(22)00390-4","article-title":"Teplizumab approval for type 1 diabetes in the USA","volume":"11","author":"Evans-Molina","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2213-8587(18)30112-8","article-title":"The challenge of modulating beta-cell autoimmunity in type 1 diabetes","volume":"7","author":"Atkinson","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-8587(18)30109-8","article-title":"Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine","volume":"7","author":"Roep","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/dc17-0806","article-title":"Type 1 diabetes TrialNet: a multifaceted approach to bringing disease-modifying therapy to clinical use in type 1 diabetes","volume":"41","author":"Bingley","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2337\/dc15-0349","article-title":"Prevention and reversal of type 1 diabetes--past challenges and future opportunities","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MED.0000000000000548","article-title":"The role of beta-cell dysfunction in early type 1 diabetes","volume":"27","author":"Sims","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.cmet.2023.06.018_bib16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/dbi20-0046","article-title":"From pancreatic \u03b2-cell gene networks to novel therapies for type 1 diabetes","volume":"70","author":"Eizirik","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142242","article-title":"Type 1 diabetes mellitus: much progress, many opportunities","volume":"131","author":"Powers","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2023.06.018_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2337\/db14-1208","article-title":"The streetlight effect in type 1 diabetes","volume":"64","author":"Battaglia","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pedi.13300","article-title":"Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes","volume":"23","author":"Taka","year":"2022","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib76","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2337\/dc21-1251","article-title":"Heterogeneity of type 1 diabetes at diagnosis supports existence of age-related endotypes","volume":"45","author":"Parviainen","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib77","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/dc19-0102","article-title":"The influence of type 2 diabetes-associated factors on type 1 diabetes","volume":"42","author":"Redondo","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2 cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib79","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2213-8587(21)00181-9","article-title":"Defining a cure for type 1 diabetes: a call to action","volume":"9","author":"Roep","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib80","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/dbi21-0012","article-title":"Diabetes: concepts of \u03b2-cell organ dysfunction and failure would lead to earlier diagnoses and prevention","volume":"70","author":"Charles","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib69","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s00125-020-05203-7","article-title":"Organisation of the human pancreas in health and in diabetes","volume":"63","author":"Atkinson","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pedi.12097","article-title":"The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings","volume":"15","author":"Pugliese","year":"2014","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib82","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1530\/JOE-21-0358","article-title":"100 years of insulin: pancreas pathology in type 1 diabetes: an evolving story","volume":"252","author":"Richardson","year":"2021","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and beta-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","article-title":"A map of human type 1 diabetes progression by imaging mass cytometry","volume":"29","author":"Damond","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cmet.2019.01.003","article-title":"Multiplexed in\u00a0situ imaging mass cytometry analysis of the human endocrine pancreas and immune system in type 1 diabetes","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trsl.2019.08.001","article-title":"Abnormalities in proinsulin processing in islets from individuals with longstanding T1D","volume":"213","author":"Sims","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.cmet.2023.06.018_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00125-019-4822-4","article-title":"Beta cells in type 1 diabetes: mass and function; sleeping or dead?","volume":"62","author":"Oram","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cmet.2017.08.013","article-title":"Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata","volume":"26","author":"Wasserfall","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2337\/db18-0305","article-title":"Low-level insulin content within abundant non-\u03b2 islet endocrine cells in long-standing type 1 diabetes","volume":"68","author":"Lam","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00125-019-05047-w","article-title":"The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening","volume":"63","author":"Jacobsen","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib28","series-title":"Proceedings of the an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases","article-title":"Heterogeneity of diabetes: \u03b2-cells, phenotypes, and precision medicine","author":"Cefalu","year":"2021"},{"key":"10.1016\/j.cmet.2023.06.018_bib29","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s00125-020-05211-7","article-title":"The clinical consequences of heterogeneity within and between different diabetes types","volume":"63","author":"Redondo","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib30","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/jc.2016-3806","article-title":"\u03b2 cells persist in T1D pancreata without evidence of ongoing \u03b2 cell turnover or neogenesis","volume":"102","author":"Lam","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.cmet.2017.03.017","article-title":"Virgin beta cells persist throughout life at a neogenic niche within pancreatic islets","volume":"25","author":"van der Meulen","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib32","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/jc.2012-1206","article-title":"Formation of a human beta-cell population within pancreatic islets is set early in life","volume":"97","author":"Gregg","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cmet.2016.09.007","article-title":"Single-cell mass cytometry analysis of the human endocrine pancreas","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib34","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","article-title":"Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes","volume":"59","author":"Richardson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T\u00a0cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cmet.2023.06.018_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00125-021-05619-9","article-title":"Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes","volume":"65","author":"Quesada-Masachs","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25367-z","article-title":"Tet2 controls the responses of \u03b2 cells to inflammation in autoimmune diabetes","volume":"12","author":"Rui","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2023.06.018_bib38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","article-title":"Targeted elimination of senescent beta cells prevents type 1 diabetes","volume":"29","author":"Thompson","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib39","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00125-021-05501-8","article-title":"Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP C, in type 1 diabetes","volume":"64","author":"Hiller","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib40","article-title":"The impact of pro-inflammatory cytokines on alternative splicing patterns in human islets","author":"Wu","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00125-019-05030-5","article-title":"Activation of the HIF1\u03b1\/PFKFB3 stress response pathway in beta cells in type 1 diabetes","volume":"63","author":"Nomoto","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib42","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1369\/00221554221138368","article-title":"Abnormal expression of an insulin synthesizing enzyme in islets of adult autoantibody positive donors","volume":"70","author":"Teitelman","year":"2022","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.cmet.2023.06.018_bib43","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db10-1797","article-title":"How does type 1 diabetes develop?: the notion of homicide or beta-cell suicide revisited","volume":"60","author":"Atkinson","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756548","article-title":"Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis","volume":"12","author":"Toren","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm.4289","article-title":"Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes","volume":"23","author":"Kracht","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib46","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/dbi20-0034","article-title":"Altered \u03b2-cell prohormone processing and secretion in type 1 diabetes","volume":"70","author":"Rodriguez-Calvo","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmet.2023.06.018_bib48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2337\/db22-0506","article-title":"DNA methylation dependent restriction of tyrosine hydroxylase contributes to pancreatic \u03b2 cell heterogeneity","volume":"72","author":"Parveen","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104379","article-title":"A discovery-based proteomics approach identifies protein disulphide isomerase (PDIA1) as a biomarker of \u03b2 cell stress in type 1 diabetes","volume":"87","author":"Syed","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.cmet.2023.06.018_bib50","article-title":"Adaptation to chronic ER stress enforces pancreatic \u03b2 cell plasticity","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2023.06.018_bib51","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/db18-0686","article-title":"HLA class II antigen processing and presentation pathway components demonstrated by transcriptome and protein analyses of islet \u03b2 cells from donors with type 1 diabetes","volume":"68","author":"Russell","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib52","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/db17-1281","article-title":"Loss of IDO1 expression from human pancreatic \u03b2-cells precedes their destruction during the development of type 1 diabetes","volume":"67","author":"Anquetil","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib53","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/db17-1006","article-title":"\u03b2-cell DNA damage response promotes islet inflammation in type 1 diabetes","volume":"67","author":"Horwitz","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2019.12.005","article-title":"Comprehensive proteomics analysis of stressed human islets identifies GDF15 as a target for type 1 diabetes intervention","volume":"31","author":"Nakayasu","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib121","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2337\/db16-1343","article-title":"Increase in pancreatic proinsulin and preservation of beta-cell mass in autoantibody-positive donors prior to type 1 diabetes onset","volume":"66","author":"Rodriguez-Calvo","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib146","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2337\/db21-0070","article-title":"Monogenic diabetes and integrated stress response genes display altered gene expression in type 1 diabetes","volume":"70","author":"Hiller","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib147","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00125-021-05387-6","article-title":"Pancreatic beta cell autophagy is impaired in type 1 diabetes","volume":"64","author":"Muralidharan","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00125-023-05888-6","article-title":"The extent and magnitude of islet T\u00a0cell infiltration as powerful tools to define the progression to type 1 diabetes","volume":"66","author":"Apaolaza","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00125-015-3752-z","article-title":"The influence of type 1 diabetes on pancreatic weight","volume":"59","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc18-1512","article-title":"Relative pancreas volume is reduced in first-degree relatives of patients with type 1 diabetes","volume":"42","author":"Campbell-Thompson","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib58","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/jama.2012.15008","article-title":"Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes","volume":"308","author":"Campbell-Thompson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cmet.2023.06.018_bib59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ajpath.2020.11.010","article-title":"Image-based machine learning algorithms for disease characterization in the human type 1 diabetes pancreas","volume":"191","author":"Tang","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cmet.2023.06.018_bib60","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2337\/dc16-1774","article-title":"Serum trypsinogen levels in type 1 diabetes","volume":"40","author":"Li","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib61","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2337\/db20-0995","article-title":"Exocrine pancreatic enzymes are a serological biomarker for type 1 diabetes staging and pancreas size","volume":"70","author":"Ross","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11892-015-0653-y","article-title":"Abnormalities of the exocrine pancreas in type 1 diabetes","volume":"15","author":"Campbell-Thompson","year":"2015","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib63","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.4158\/EP-2020-0295","article-title":"Exocrine pancreas dysfunction in type 1 diabetes","volume":"26","author":"Foster","year":"2020","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cmet.2023.06.018_bib64","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00125-013-3043-5","article-title":"The diagnosis of insulitis in human type 1 diabetes","volume":"56","author":"Campbell-Thompson","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00428-021-03055-z","article-title":"Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens","volume":"479","author":"Smeets","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.cmet.2023.06.018_bib66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/isl.3.4.15728","article-title":"Insulitis in human type 1 diabetes: the quest for an elusive lesion","volume":"3","author":"In't Veld","year":"2011","journal-title":"Islets"},{"key":"10.1016\/j.cmet.2023.06.018_bib67","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00125-021-05453-z","article-title":"Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes","volume":"64","author":"Korpos","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6527","article-title":"Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes","volume":"7","author":"Apaolaza","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cmet.2023.06.018_bib113","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao4013","article-title":"Islet-reactive CD8+ T\u00a0cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors","volume":"3","author":"Culina","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102628","article-title":"HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes","volume":"119","author":"Benkahla","year":"2021","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.cmet.2023.06.018_bib70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ng.3531","article-title":"Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes","volume":"48","author":"Dooley","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cmet.2023.06.018_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1032822","article-title":"Development of type 1 diabetes may occur through a type 2 diabetes mechanism","volume":"13","author":"Josefsen","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2023.06.018_bib72","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00281-014-0438-4","article-title":"Insulitis in human type 1 diabetes: a comparison between patients and animal models","volume":"36","author":"In\u2019t Veld","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cmet.2023.06.018_bib73","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/db16-1551","article-title":"Comparative pathogenesis of autoimmune diabetes in humans, NOD mice, and canines: has a valuable animal model of type 1 diabetes been overlooked?","volume":"66","author":"O'Kell","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib74","doi-asserted-by":"crossref","DOI":"10.3791\/62207","article-title":"Observing islet function and islet-immune cell interactions in live pancreatic tissue slices","author":"Huber","year":"2021","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.cmet.2023.06.018_bib100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107208118","article-title":"Human islet T\u00a0cells are highly reactive to preproinsulin in type 1 diabetes","volume":"118","author":"Anderson","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2023.06.018_bib83","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41574-021-00542-w","article-title":"One hundred years of insulin therapy","volume":"17","author":"Mathieu","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib84","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41574-020-00450-5","article-title":"Shortening the paths to type 1 diabetes mellitus prevention","volume":"17","author":"Ziegler","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib85","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cmet.2023.06.018_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/nyas.14572","article-title":"Pancreatic islet reserve in type 1 diabetes","volume":"1495","author":"Flatt","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cmet.2023.06.018_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122146","article-title":"Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes","volume":"3","author":"Vecchio","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.cmet.2023.06.018_bib88","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2337\/db12-1345","article-title":"Reduction of circulating neutrophils precedes and accompanies type 1 diabetes","volume":"62","author":"Valle","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib89","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cmet.2023.06.018_bib90","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc16-2127","article-title":"Insulitis in autoantibody-positive pancreatic donor with history of gestational diabetes mellitus","volume":"40","author":"Jackson","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib91","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib92","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes","volume":"63","author":"Arif","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib93","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T\u00a0cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib94","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T\u00a0cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MED.0000000000000323","article-title":"Narrowing in on the anti-\u03b2 cell-specific T\u00a0cells: looking 'where the action is'","volume":"24","author":"Kent","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.cmet.2023.06.018_bib96","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0915-y","article-title":"Deciphering the pathogenesis of human type 1 diabetes (T1D) by interrogating T\u00a0cells from the \"scene of the crime\"","volume":"17","author":"Kent","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200818","article-title":"Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus","volume":"13","author":"Laban","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmet.2023.06.018_bib98","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/db16-1025","article-title":"Islet-derived CD4 T\u00a0cells targeting proinsulin in human autoimmune diabetes","volume":"66","author":"Michels","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88242","article-title":"Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes","volume":"1","author":"Seay","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.cmet.2023.06.018_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.622647","article-title":"Proinsulin-reactive CD4 T\u00a0cells in the islets of type 1 diabetes organ donors","volume":"12","author":"Landry","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cmet.2023.06.018_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667989","article-title":"Neoepitopes in type 1 diabetes: etiological insights, biomarkers and therapeutic targets","volume":"12","author":"Rodriguez-Calvo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib103","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","article-title":"Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating na\u00efve CD8+ T\u00a0cells in type 1 diabetic and healthy donors","volume":"28","author":"Gonzalez-Duque","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib104","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00125-017-4508-8","article-title":"Combinatorial detection of autoreactive CD8+ T\u00a0cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T\u00a0cell Workshop","volume":"61","author":"James","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777788","article-title":"Using the T\u00a0cell receptor as a biomarker in type 1 diabetes","volume":"12","author":"Nakayama","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib106","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2337\/db19-0119","article-title":"Standardizing T-cell biomarkers in type 1 diabetes: challenges and recent advances","volume":"68","author":"Ahmed","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib107","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ymthe.2021.04.034","article-title":"CAR- and TRuC-redirected regulatory T\u00a0cells differ in capacity to control adaptive immunity to FVIII","volume":"29","author":"Rana","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cmet.2023.06.018_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102417","article-title":"Innate inflammation drives NK cell activation to impair Treg activity","volume":"108","author":"Dean","year":"2020","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.cmet.2023.06.018_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574447","article-title":"Immunomodulatory dual-sized microparticle system conditions human antigen presenting cells into a tolerogenic phenotype in\u00a0vitro and inhibits type 1 diabetes-specific autoreactive T\u00a0cell responses","volume":"11","author":"Brusko","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db16-0846","article-title":"Interferon gamma limits diabetogenic CD8 T-cell effector responses in type-1 diabetes","volume":"66","author":"Driver","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib111","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2337\/db17-0106","article-title":"Type 1 interferons potentiate human CD8+ T\u00a0cell cytotoxicity through a STAT4 and granzyme B dependent pathway","volume":"66","author":"Newby","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01313","article-title":"Avidity and bystander suppressive capacity of human regulatory T\u00a0cells expressing de novo autoreactive T-cell receptors in type 1 diabetes","volume":"8","author":"Yeh","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.591083","article-title":"Chemokines as drivers of the autoimmune destruction in type 1 diabetes: opportunity for therapeutic intervention in consideration of an optimal treatment schedule","volume":"11","author":"Christen","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2023.06.018_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-014-0552-7","article-title":"Extracellular matrix components in the pathogenesis of type 1 diabetes","volume":"14","author":"Bogdani","year":"2014","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib117","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.2337\/db14-0549","article-title":"Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes","volume":"63","author":"Rodriguez-Calvo","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib118","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/db09-1855","article-title":"Banting Lecture 2009: an unfinished journey: molecular pathogenesis to prevention of type 1A diabetes","volume":"59","author":"Eisenbarth","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib119","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00125-015-3820-4","article-title":"Insulitis and characterisation of infiltrating T\u00a0cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes","volume":"59","author":"Krogvold","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/cei.12698","article-title":"Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies","volume":"182","author":"Wiberg","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib122","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nri2192","article-title":"Type 1 diabetes as a relapsing-remitting disease?","volume":"7","author":"von Herrath","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","article-title":"Type 1 diabetes: etiology, immunology, and therapeutic strategies","volume":"91","author":"van Belle","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cmet.2023.06.018_bib124","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3422","article-title":"Type 1 diabetes: translating mechanistic observations into effective clinical outcomes","volume":"13","author":"Herold","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib125","article-title":"New insights into the role of autoreactive CD8 T\u00a0cells and cytokines in human type 1 diabetes","volume":"11","author":"Bender","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2023.06.018_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00232","article-title":"Type I interferon is a catastrophic feature of the diabetic islet microenvironment","volume":"8","author":"Newby","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2023.06.018_bib127","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg5794","article-title":"Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice","volume":"15","author":"Hu","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib128","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2337\/db21-0091","article-title":"Reduced follicular regulatory T\u00a0cells in spleen and pancreatic lymph nodes of patients with type 1 diabetes","volume":"70","author":"Vecchione","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-gamma drives programmed death-ligand 1 expression on islet \u03b2 cells to limit T\u00a0cell function during autoimmune diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmet.2023.06.018_bib131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11892-021-01384-6","article-title":"The role of programmed Death-1 in type 1 diabetes","volume":"21","author":"Tucker","year":"2021","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.739048","article-title":"The immunoregulatory role of the signal regulatory protein family and CD47 signaling pathway in type 1 diabetes","volume":"12","author":"Sharp","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib133","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200464","article-title":"MERTK on mononuclear phagocytes regulates T\u00a0cell antigen recognition at autoimmune and tumor sites","volume":"218","author":"Lindsay","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib134","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MED.0b013e32835edb89","article-title":"Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease","volume":"20","author":"Skog","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.cmet.2023.06.018_bib135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1464-5491.1986.tb00722.x","article-title":"Lawrence lecture. Death of a beta cell: homicide or suicide?","volume":"3","author":"Bottazzo","year":"1986","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib136","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac184","article-title":"Inside the \u03b2 cell: molecular stress response pathways in diabetes pathogenesis","volume":"164","author":"Kulkarni","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2023.06.018_bib137","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.2337\/db16-0180","article-title":"Aberrant accumulation of the diabetes autoantigen GAD65 in Golgi membranes in conditions of ER stress and autoimmunity","volume":"65","author":"Phelps","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib138","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156243","article-title":"\u03b1 Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody-positive individuals","volume":"132","author":"Doliba","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2023.06.018_bib139","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/db12-0432","article-title":"The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human","volume":"62","author":"Korpos","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cei.13349","article-title":"Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction","volume":"198","author":"Peters","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib141","article-title":"Localization of enteroviral RNA within the pancreas in donors with T1D and T1D-associated autoantibodies","volume":"2","author":"Geravandi","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib142","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/hmg\/ddz094","article-title":"Cellular stressors may alter islet hormone cell proportions by moderation of alternative splicing patterns","volume":"28","author":"Jeffery","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cmet.2023.06.018_bib143","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-022-05779-2","article-title":"Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study","volume":"65","author":"Krogvold","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.833141","article-title":"Increased expression of viral sensor MDA5 in pancreatic islets and in hormone-negative endocrine cells in recent onset type 1 diabetic donors","volume":"13","author":"Nigi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2023.06.018_bib145","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s00125-018-4704-1","article-title":"Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells","volume":"61","author":"Ifie","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002552","article-title":"The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines","volume":"8","author":"Eizirik","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cmet.2023.06.018_bib149","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/db11-1293","article-title":"Islet \u03b2 cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model","volume":"61","author":"Tersey","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib150","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s00125-012-2604-3","article-title":"Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes","volume":"55","author":"Marhfour","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib151","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2337\/db18-0295","article-title":"Inflammation-induced citrullinated glucose-regulated Protein 78 elicits immune responses in human type 1 diabetes","volume":"67","author":"Buitinga","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib152","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/db17-1166","article-title":"Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4+ T\u00a0cells in patients with type 1 diabetes","volume":"67","author":"Marre","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib153","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-017-4536-4","article-title":"IFN-\u03b1 induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells","volume":"61","author":"Coomans de Brach\u00e8ne","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib154","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00125-018-4712-1","article-title":"Biomarkers of islet beta cell stress and death in type 1 diabetes","volume":"61","author":"Sims","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib155","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2337\/dc15-2849","article-title":"Elevations in the fasting serum proinsulin-to-C-pepT1De ratio precede the onset of type 1 diabetes","volume":"39","author":"Sims","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib156","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.2337\/db15-0430","article-title":"Elevations in circulating methylated and unmethylated preproinsulin DNA in new-onset type 1 diabetes","volume":"64","author":"Fisher","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib157","doi-asserted-by":"crossref","first-page":"19018","DOI":"10.1073\/pnas.1111008108","article-title":"Detection of \u03b2 cell death in diabetes using differentially methylated circulating DNA","volume":"108","author":"Akirav","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2023.06.018_bib158","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/clinem\/dgaa008","article-title":"Circulating unmethylated insulin DNA as a biomarker of human beta cell death: a multi-laboratory assay comparison","volume":"105","author":"Speake","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib159","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-020-00906-5","article-title":"Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes","volume":"12","author":"Syed","year":"2020","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.cmet.2023.06.018_bib160","doi-asserted-by":"crossref","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2023.06.018_bib161","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136579","article-title":"Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic \u03b2 cells","volume":"5","author":"Neiman","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cmet.2023.06.018_bib162","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/diab.33.8.717","article-title":"Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose","volume":"33","author":"Srikanta","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib163","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00400930","article-title":"Altered islet beta-cell function before the onset of type 1 (insulin-dependent) diabetes mellitus","volume":"35","author":"Lo","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib164","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1210\/jc.2015-3756","article-title":"\u03b2 cell mass in nondiabetic autoantibody-positive subjects: an analysis based on the Network for Pancreatic Organ Donors Database","volume":"101","author":"Diedisheim","year":"2016","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib165","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db14-1911","article-title":"Function of isolated pancreatic islets from patients at onset of type 1 diabetes: insulin secretion can be restored after some days in a nondiabetogenic environment in\u00a0vitro: results from the DiViD study","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib166","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/dmrr.460","article-title":"Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients","volume":"20","author":"Lupi","year":"2004","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cmet.2023.06.018_bib167","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146788","article-title":"Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional \u03b2 cells in predicting diabetes","volume":"131","author":"Mezza","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2023.06.018_bib168","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-013-3159-7","article-title":"Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box","volume":"57","author":"Atkinson","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib169","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dc17-2625","article-title":"Proinsulin secretion is a persistent feature of type 1 diabetes","volume":"42","author":"Sims","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/dc11-1236","article-title":"Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay","volume":"35","author":"Wang","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib171","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","article-title":"The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells","volume":"57","author":"Oram","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib172","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00125-007-0794-x","article-title":"Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis","volume":"50","author":"Butler","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib173","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/jc.2017-01713","article-title":"Assessment of \u03b2 cell mass and function by AIRmax and intravenous glucose in high-risk subjects for type 1 diabetes","volume":"102","author":"Hao","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2020.110846","article-title":"The vascular architecture of the pancreatic islets: a homage to August Krogh","volume":"252","author":"Muratore","year":"2021","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"10.1016\/j.cmet.2023.06.018_bib175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2018.02.016","article-title":"The pericyte of the pancreatic islet regulates capillary diameter and local blood flow","volume":"27","author":"Alma\u00e7a","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.667170","article-title":"The role of vascular cells in pancreatic beta-cell function","volume":"12","author":"Burganova","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cmet.2023.06.018_bib177","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1369\/0022155418778546","article-title":"Islet microvasculature alterations with loss of beta-cells in patients with type 1 diabetes","volume":"67","author":"Canzano","year":"2019","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.cmet.2023.06.018_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276942","article-title":"Altered microvasculature in pancreatic islets from subjects with type 1 diabetes","volume":"17","author":"Granlund","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cmet.2023.06.018_bib179","doi-asserted-by":"crossref","first-page":"E251","DOI":"10.1152\/ajpendo.00246.2022","article-title":"Human pancreatic capillaries and nerve fibers persist in type 1 diabetes despite beta cell loss","volume":"324","author":"Richardson","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib180","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00125-020-05345-8","article-title":"Structural and functional polarisation of human pancreatic beta cells in islets from organ donors with and without type 2 diabetes","volume":"64","author":"Cottle","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib181","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/db19-1034","article-title":"Integrated pancreatic blood flow: bidirectional microcirculation between endocrine and exocrine pancreas","volume":"69","author":"Dybala","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib182","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.matbio.2011.10.004","article-title":"Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration","volume":"31","author":"Evanko","year":"2012","journal-title":"Matrix Biol."},{"key":"10.1016\/j.cmet.2023.06.018_bib183","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/db13-1658","article-title":"Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis","volume":"63","author":"Bogdani","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib184","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-019-05066-7","article-title":"Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates","volume":"63","author":"Bogdani","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib185","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1172\/JCI79271","article-title":"Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis","volume":"125","author":"Nagy","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2023.06.018_bib186","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI46177","article-title":"Heparan sulfate and heparanase play key roles in mouse \u03b2 cell survival and autoimmune diabetes","volume":"122","author":"Ziolkowski","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2023.06.018_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191360","article-title":"Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans","volume":"13","author":"Simeonovic","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmet.2023.06.018_bib188","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41583-021-00523-y","article-title":"The sympathetic nervous system in development and disease","volume":"22","author":"Scott-Solomon","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cmet.2023.06.018_bib189","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.celrep.2013.06.019","article-title":"Sympathetic innervation during development is necessary for pancreatic islet architecture and functional maturation","volume":"4","author":"Borden","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib190","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00125-022-05691-9","article-title":"Unravelling innervation of pancreatic islets","volume":"65","author":"Hampton","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib191","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/db16-0284","article-title":"Human type 1 diabetes is characterized by an early, marked, sustained, and islet-selective loss of sympathetic nerves","volume":"65","author":"Mundinger","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-85659-8","article-title":"Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes","volume":"11","author":"Campbell-Thompson","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib193","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ca.20543","article-title":"Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes","volume":"20","author":"Saisho","year":"2007","journal-title":"Clin. Anat."},{"key":"10.1016\/j.cmet.2023.06.018_bib194","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1084\/jem.11.2.266","article-title":"A study of the pathological anatomy of the pancreas in ninety cases of diabetes mellitus","volume":"11","author":"Cecil","year":"1909","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01237787","article-title":"Exocrine pancreatic function in juvenile diabetics","volume":"20","author":"Domschke","year":"1975","journal-title":"Am. J. Dig. Dis."},{"key":"10.1016\/j.cmet.2023.06.018_bib196","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/gut.17.9.685","article-title":"Exocrine pancreatic function in juvenile-onset diabetes mellitus","volume":"17","author":"Frier","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.cmet.2023.06.018_bib197","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jcp.33.11.1102","article-title":"Serum isoamylase activities in diabetes mellitus","volume":"33","author":"Foo","year":"1980","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.cmet.2023.06.018_bib198","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/jcp.36.2.200","article-title":"Low pancreatic lipase in insulin-dependent diabetics","volume":"36","author":"Junglee","year":"1983","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.cmet.2023.06.018_bib199","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000087660","article-title":"Follow-up of exocrine pancreatic function in type-1 diabetes mellitus","volume":"72","author":"Creutzfeldt","year":"2005","journal-title":"Digestion"},{"key":"10.1016\/j.cmet.2023.06.018_bib200","doi-asserted-by":"crossref","first-page":"E2109","DOI":"10.1210\/jc.2012-1815","article-title":"Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes","volume":"97","author":"Williams","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib201","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dc18-1507","article-title":"Pancreas volume declines during the first year after diagnosis of type 1 diabetes and exhibits altered diffusion at disease onset","volume":"42","author":"Virostko","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib202","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1073\/pnas.1424993112","article-title":"Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients","volume":"112","author":"Gaglia","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2023.06.018_bib203","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61759-9","article-title":"Repeatability and reproducibility of pancreas volume measurements using MRI","volume":"10","author":"Williams","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib204","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2337\/db19-0554","article-title":"Temporal analysis of amylase expression in control, autoantibody-positive, and type 1 diabetes pancreatic tissues","volume":"69","author":"Kusmartseva","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib205","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00125-020-05155-y","article-title":"Decreased pancreatic acinar cell number in type 1 diabetes","volume":"63","author":"Wright","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib206","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.1105788","article-title":"Exocrine pancreas: evidence for topographic partition of secretory function","volume":"190","author":"Malaisse-Lagae","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.cmet.2023.06.018_bib207","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1900\/RDS.2016.13.132","article-title":"Pancreas volume and fat deposition in diabetes and normal physiology: consideration of the interplay between endocrine and exocrine pancreas","volume":"13","author":"Saisho","year":"2016","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.cmet.2023.06.018_bib208","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s00125-016-3889-4","article-title":"Pancreatic duct hyperplasia\/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et\u00a0al [letter] and Saisho Y [letter]","volume":"59","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2023.06.018_bib209","first-page":"200","article-title":"Increased proliferation of the pancreatic duct gland compartment in type 1 diabetes","volume":"102","author":"Moin","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib210","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/pmic.201500333","article-title":"Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profile","volume":"16","author":"Liu","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.cmet.2023.06.018_bib211","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.2337\/dc13-0203","article-title":"Increased complement activation in human type 1 diabetes pancreata","volume":"36","author":"Rowe","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2023.06.018_bib212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/pedi.12305","article-title":"The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?","volume":"16","author":"Li","year":"2015","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cmet.2023.06.018_bib213","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc5586","article-title":"The healthy exocrine pancreas contains preproinsulin-specific CD8 T\u00a0cells that attack islets in type 1 diabetes","volume":"6","author":"Bender","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cmet.2023.06.018_bib214","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MPA.0000000000002073","article-title":"Type 1 diabetes in acute pancreatitis consortium: from concept to reality","volume":"51","author":"Serrano","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.cmet.2023.06.018_bib215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MPA.0000000000002076","article-title":"Evaluating the immunopathogenesis of diabetes after acute pancreatitis in the diabetes related to acute pancreatitis and its mechanisms study: from the Type 1 Diabetes in Acute Pancreatitis Consortium","volume":"51","author":"Casu","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.cmet.2023.06.018_bib216","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120028119","article-title":"A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes","volume":"119","author":"Girdhar","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2023.06.018_bib217","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/S0140-6736(16)30507-4","article-title":"Environmental risk factors for type 1 diabetes","volume":"387","author":"Rewers","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2023.06.018_bib218","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-018-0620-2","article-title":"The human gut microbiome in early-onset type 1 diabetes from the TEDDY study","volume":"562","author":"Vatanen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2023.06.018_bib219","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2020-322630","article-title":"Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial","volume":"70","author":"de Groot","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cmet.2023.06.018_bib220","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","article-title":"Prospective virome analyses in young children at increased genetic risk for type 1 diabetes","volume":"25","author":"Vehik","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2023.06.018_bib221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-020-01370-4","article-title":"The \u03b2-cell genomic landscape in T1D: implications for disease pathogenesis","volume":"21","author":"Ramos-Rodr\u00edguez","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cmet.2023.06.018_bib222","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"issue":"suppl 2","key":"10.1016\/j.cmet.2023.06.018_bib223","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/dom.13388","article-title":"When one becomes many-alternative splicing in \u03b2 cell function and failure","volume":"20","author":"Alvelos","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib224","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cmet.2023.06.018_bib225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cmet.2023.06.018_bib226","series-title":"Number of deceased organ donors in the United States in 2021, by age group","author":"Elflein","year":"2022"},{"key":"10.1016\/j.cmet.2023.06.018_bib227","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New frontiers in the treatment of type 1 diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2023.06.018_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.592349","article-title":"Quantitative magnetic resonance imaging of the pancreas of individuals with diabetes","volume":"11","author":"Virostko","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413123002280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413123002280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:45:06Z","timestamp":1761551106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413123002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":228,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1550413123002280"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2023.06.018","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenic \u201csymphony\u201d in type 1 diabetes: A disorder of the immune system, \u03b2 cells, and exocrine pancreas","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2023.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}